XFOR - X4 Pharmaceuticals Inc
IEX Last Trade
0.7038
0.011 1.563%
Share volume: 732,798
Last Updated: Fri 30 Aug 2024 09:59:56 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.69
0.01
1.59%
Summary score
13%
Profitability
8%
Dept financing
8%
Liquidity
50%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-26.46%
Return on assets
-18.72%
Return on sales
0%
Return on invested capital
42.62%
Total debt ratio
55.14%
Debt ratio change over timeo
-0.84%
Current Ratio
6.92%
Quick Ratio
0%
Cash Position Ratio
6.6%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-13.65%
Return on assets
-8.96%
Return on sales
0%
Return on invested capital
-61.43%
Total debt ratio
24.13%
Debt ratio change over timeo
-1.44%
Current Ratio
12.2%
Quick Ratio
0%
Cash Position Ratio
11.67%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-14.44%
Return on assets
-10.28%
Return on sales
0%
Return on invested capital
-69.26%
Total debt ratio
26.41%
Debt ratio change over time
-1.56%
Current Ratio
10.19%
Quick Ratio
0%
Cash Position Ratio
9.62%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-119.34%
Return on assets
-107.34%
Return on sales
0%
Return on invested capital
17.23%
Total debt ratio
-83.64%
Debt ratio change over time
-0.84%
Current Ratio
-5.25%
Quick Ratio
0%
Cash Position Ratio
-5.93%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XFOR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -26.46% | -3.05% | 11.55% | 6.27% |
| Return on assets | -18.72% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | 42.62% | 5.09% | 7.99% | 13.19% |
| Profitability | 25% | 39% | 72% | 66% |
| Total debt ratio | 55.14% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.84% | 6.09% | 6.03% | 1.53% |
| Dept financing | 14% | 50% | 43% | 14% |
| Current Ratio | 12.2% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 11.67% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 18% | 40% | 41% |
| Short-term ratios | XFOR | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.65% | -25.62% | 17.94% | 7.14% |
| Return on assets | -8.96% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -61.43% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 24.13% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.44% | -23.44% | 9.66% | 0.6% |
| Dept financing | 6% | 25% | 45% | 8% |
| Current Ratio | 12.2% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 11.67% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 25% | 21% | 35% |